呼吸器合胞体ウイルス（RSV）診断薬の世界市場レポート 2025年

呼吸器合胞体ウイルス（RSV）診断薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.7％で16億8,000万米ドルに成長します。予測期間中に成長が見込まれる背景には、呼吸器合胞体ウイルス（RSV）感染症の流行増加、RSV診断に対する意識の高まり、ヘルスケアインフラの拡大、世界のヘルスケア支出の増加、高齢化などがあります。主な動向としては、分子診断技術の進歩、診断機器の技術革新、迅速診断検査（RDT）の採用、企業による診断検査ポートフォリオの拡大、遺伝子診断およびプロテオミクス診断の進展などが挙げられます。

呼吸器疾患の有病率の増加が呼吸器合胞体ウイルス（RSV）診断薬の需要を牽引すると予想されます。喘息、慢性閉塞性肺疾患（COPD）、肺炎、呼吸器感染症などの呼吸器疾患は、大気汚染、喫煙、気候変動、都市化、慢性疾患の罹患率の上昇などの要因により、より広まりつつあります。RSV診断薬は、感染を正確かつタイムリーに特定し、適切な治療、管理、重篤な合併症の予防を可能にする重要な役割を担っています。例えば、2024年11月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、2022年にオーストラリアで推定280万人（人口の11%）が喘息と共存していると報告しました。喘息は、2023年には全疾患負担の2.5％、全呼吸器疾患による負担の35％を占め、2022年の喘息関連死は467人でした。したがって、呼吸器疾患の有病率の上昇がRSV診断薬市場の成長を促進しています。

RSV診断薬市場の主要企業は、効率と精度を高めるために革新的なマルチウイルス診断検査に注力しています。マルチウイルス診断検査は、単一の患者サンプルからRSV、インフルエンザ、COVID-19などの複数の呼吸器ウイルスを同時に検出することを可能にします。例えば、2023年1月、米国の臨床検査会社であるSonora Quest Laboratories社は、1つの検体からCOVID-19、RSV、インフルエンザを検出する新しい分子診断検査を発表しました。これらの検査を組み合わせることで、プロセスが合理化され、複数のサンプルの必要性が減り、より迅速で包括的な診断が可能になります。このアプローチにより、ヘルスケア・プロバイダーは迅速な治療方針を決定することができ、これらのウイルスの蔓延を防ぐことができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界呼吸器合胞体ウイルス（RSV）診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場：成長率分析
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場の実績：規模と成長, 2019-2024
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界呼吸器合胞体ウイルス（RSV）診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キットとアッセイ
• 機器
• 試薬
• その他の製品タイプ
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分子診断
• 免疫測定
• 迅速抗原検出検査
• その他のテクノロジー
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場サンプルタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻腔ぬぐい液
• 咽頭ぬぐい液検査
• 気管支肺胞洗浄
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断検査室
• 在宅ケア設定
• その他のエンドユーザー
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場キットとアッセイの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 迅速抗原検出キット
• PCRベースのアッセイ
• 血清学的検査
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCRアナライザー
• 免疫測定分析装置
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場、試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCR試薬
• 抗体試薬
• 酵素試薬
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• サンプル収集装置
• 交通メディア

第7章 地域別・国別分析

• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の呼吸器合胞体ウイルス（RSV）診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 呼吸器合胞体ウイルス（RSV）診断薬市場：競合情勢
• 呼吸器合胞体ウイルス（RSV）診断薬市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Becton, Dickinson, and Company
• Quest Diagnostics Incorporated
• Hologic Inc.
• BIOMERIEUX SA
• QuidelOrtho Corporation
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A.
• Acon Laboratories Inc.
• Cepheid Inc.
• Meridian Bioscience Inc.
• Seegene Inc.
• LumiraDx Ltd.
• Sekisui Diagnostics Ltd.
• Boditech Med Inc.
• Trinity Biotech plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 呼吸器合胞体ウイルス（RSV）診断薬市場2029：新たな機会を提供する国
• 呼吸器合胞体ウイルス（RSV）診断薬市場2029：新たな機会を提供するセグメント
• 呼吸器合胞体ウイルス（RSV）診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Respiratory syncytial virus (RSV) diagnostics encompass the tests and methods used to detect RSV in patients, typically through respiratory samples such as nasal or throat swabs. These diagnostics are essential for identifying RSV infections, which can cause respiratory illnesses in infants, young children, and the elderly, aiding in appropriate treatment and disease management.

The primary types of RSV diagnostic products include kits and assays, instruments, reagents, and others. Kits and assays are pre-packaged sets containing reagents, materials, and instructions for conducting specific diagnostic tests. Various technologies are used for RSV detection, including molecular diagnostics, immunoassays, and rapid antigen detection tests. Sample types include nasal swabs, throat swabs, and bronchoalveolar lavage. These diagnostics are utilized in hospitals, diagnostic laboratories, home care settings, and other healthcare environments.

The respiratory syncytial virus (RSV) diagnostics market research report is one of a series of new reports from The Business Research Company that provides respiratory syncytial virus (RSV) diagnostics market statistics, including respiratory syncytial virus (RSV) diagnostics industry global market size, regional shares, competitors with a respiratory syncytial virus (RSV) diagnostics market share, detailed respiratory syncytial virus (RSV) diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory syncytial virus (RSV) diagnostics industry. This respiratory syncytial virus (RSV) diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory syncytial virus (RSV) diagnostics market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth during the historic period was driven by the increasing adoption of point-of-care diagnostics, government initiatives to enhance RSV diagnostics, the rising incidence of respiratory diseases in children, the growth of hospital-acquired infections, and the growing demand for non-invasive diagnostic methods.

The respiratory syncytial virus (RSV) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The projected growth during the forecast period is driven by the increasing prevalence of respiratory syncytial virus (RSV) infections, rising awareness of RSV diagnostics, expanding healthcare infrastructure, growing global healthcare spending, and the aging population. Key trends include advancements in molecular diagnostic technologies, technological innovations in diagnostic devices, the adoption of rapid diagnostic tests (RDTs), the expansion of diagnostic test portfolios by companies, and progress in genetic and proteomic diagnostics.

The increasing prevalence of respiratory diseases is expected to drive the demand for respiratory syncytial virus (RSV) diagnostics. Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections, are becoming more widespread due to factors such as air pollution, smoking, climate change, urbanization, and the rising incidence of chronic conditions. RSV diagnostics play a crucial role in identifying infections accurately and in a timely manner, enabling appropriate treatment, management, and prevention of severe complications, particularly in vulnerable populations. For instance, in November 2024, the Australian Institute of Health and Welfare reported that an estimated 2.8 million people (11% of the population) in Australia were living with asthma in 2022. Asthma accounted for 2.5% of the total disease burden and 35% of the burden from all respiratory conditions in 2023, with 467 asthma-related deaths in 2022. Therefore, the rising prevalence of respiratory diseases is fueling growth in the RSV diagnostics market.

Leading companies in the RSV diagnostics market are focusing on innovative multi-virus diagnostic testing to enhance efficiency and accuracy. Multi-virus diagnostic testing enables the simultaneous detection of multiple respiratory viruses, such as RSV, influenza, and COVID-19, from a single patient sample. For example, in January 2023, Sonora Quest Laboratories, a US-based clinical laboratory testing company, introduced a new molecular diagnostic test that detects COVID-19, RSV, and influenza using a single sample. By combining these tests, the process is streamlined, reducing the need for multiple samples and enabling faster, more comprehensive diagnoses. This approach allows healthcare providers to make quicker treatment decisions and helps prevent the spread of these viruses.

In November 2023, Medix Biochemica, a Finland-based biotechnology company, acquired ViroStat LLC for an undisclosed amount. This acquisition expands Medix Biochemica's infectious disease diagnostic portfolio by integrating ViroStat's expertise in monoclonal antibodies and antigen detection kits for RSV testing. ViroStat LLC, a US-based company, specializes in developing diagnostic solutions for various infectious diseases, including RSV, further strengthening Medix Biochemica's position in the RSV diagnostics market.

Major players in the respiratory syncytial virus (RSV) diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson, and Company, Quest Diagnostics Incorporated, Hologic Inc., BIOMERIEUX SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Acon Laboratories Inc., Cepheid Inc., Meridian Bioscience Inc., Seegene Inc., LumiraDx Ltd., Sekisui Diagnostics Ltd., Boditech Med Inc., Trinity Biotech plc, R-Biopharm AG, GeneTex Inc., Creative Diagnostics, Certest Biotec S.L., Clarity Diagnostics LLC, Genes 2Me LLP, Coris BioConcept S.A.

North America was the largest region in the respiratory syncytial virus (RSV) diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory syncytial virus (RSV) diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Respiratory Syncytial Virus (RSV) Diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory syncytial virus (RSV) diagnostics market consists of revenues earned by entities by providing services such as diagnostic consultation, research and development support, training and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory syncytial virus (RSV) diagnostics market also includes sales of immunofluorescence test kits, multiplex panels, sample collection devices and automated testing instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory syncytial virus (rsv) diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory syncytial virus (rsv) diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory syncytial virus (rsv) diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Kits And Assays; Instruments; Reagents; Other Product Types
• 2) By Technology: Molecular Diagnostics; Immunoassays; Rapid Antigen Detection Tests; Other Technologies
• 3) By Sample Type: Nasal Swabs; Throat Swabs; Bronchoalveolar Lavage
• 4) By End User: Hospitals; Diagnostic Laboratories; Home Care Settings; Other End Users
• Subsegments:
• 1) By Kits And Assays: Rapid Antigen Detection Kits; PCR-based Assays; Serological Assays
• 2) By Instruments: PCR Analyzers; Immunoassay Analyzers
• 3) By Reagents: PCR Reagents; Antibody Reagents; Enzyme Reagents
• 4) By Other Product Types: Sample Collection Devices; Transport Media
• Companies Mentioned:F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Syncytial Virus (RSV) Diagnostics Market Characteristics

3. Respiratory Syncytial Virus (RSV) Diagnostics Market Trends And Strategies

4. Respiratory Syncytial Virus (RSV) Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Respiratory Syncytial Virus (RSV) Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Respiratory Syncytial Virus (RSV) Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Growth Rate Analysis
• 5.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Total Addressable Market (TAM)

6. Respiratory Syncytial Virus (RSV) Diagnostics Market Segmentation

• 6.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits And Assays
• Instruments
• Reagents
• Other Product Types
• 6.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunoassays
• Rapid Antigen Detection Tests
• Other Technologies
• 6.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal Swabs
• Throat Swabs
• Bronchoalveolar Lavage
• 6.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Home Care Settings
• Other End Users
• 6.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Kits And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Antigen Detection Kits
• PCR-based Assays
• Serological Assays
• 6.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Analyzers
• Immunoassay Analyzers
• 6.7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Reagents
• Antibody Reagents
• Enzyme Reagents
• 6.8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Collection Devices
• Transport Media

7. Respiratory Syncytial Virus (RSV) Diagnostics Market Regional And Country Analysis

• 7.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market

• 8.1. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Syncytial Virus (RSV) Diagnostics Market

• 9.1. China Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 9.2. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Syncytial Virus (RSV) Diagnostics Market

• 10.1. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market

• 11.1. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 11.2. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market

• 12.1. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market

• 13.1. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market

• 14.1. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 14.2. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

• 15.1. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 15.2. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Syncytial Virus (RSV) Diagnostics Market

• 16.1. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market

• 17.1. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Syncytial Virus (RSV) Diagnostics Market

• 18.1. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market

• 19.1. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market

• 20.1. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

• 21.1. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 21.2. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market

• 22.1. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Syncytial Virus (RSV) Diagnostics Market

• 23.1. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 23.2. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Syncytial Virus (RSV) Diagnostics Market

• 24.1. USA Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 24.2. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market

• 25.1. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 25.2. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Syncytial Virus (RSV) Diagnostics Market

• 26.1. South America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 26.2. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market

• 27.1. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market

• 28.1. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 28.2. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market

• 29.1. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
• 29.2. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape
• 30.2. Respiratory Syncytial Virus (RSV) Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Syncytial Virus (RSV) Diagnostics Market Other Major And Innovative Companies

• 31.1. Becton, Dickinson, and Company
• 31.2. Quest Diagnostics Incorporated
• 31.3. Hologic Inc.
• 31.4. BIOMERIEUX SA
• 31.5. QuidelOrtho Corporation
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. DiaSorin S.p.A.
• 31.8. Acon Laboratories Inc.
• 31.9. Cepheid Inc.
• 31.10. Meridian Bioscience Inc.
• 31.11. Seegene Inc.
• 31.12. LumiraDx Ltd.
• 31.13. Sekisui Diagnostics Ltd.
• 31.14. Boditech Med Inc.
• 31.15. Trinity Biotech plc

32. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Syncytial Virus (RSV) Diagnostics Market

34. Recent Developments In The Respiratory Syncytial Virus (RSV) Diagnostics Market

35. Respiratory Syncytial Virus (RSV) Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer